Currently, the storage and transportation of mRNA vaccines typically rely on ultra-low temperature conditions. To improve their stability and extend shelf life, recent studies have been devoted to converting liquid formulations into solid forms using drying technology. Among them, freeze-drying (lyophilization) is an effective strategy that freezes samples and removes moisture through primary (sublimation) and secondary (desorption) drying stages, maximally preserving the structural integrity and biological activity of mRNA vaccines. The significant reduction in moisture content effectively inhibits the rate of hydrolysis of mRNA, which is considered the primary factor contributing to the instability of mRNA vaccines. However, the freeze-drying process itself and its accompanying stresses pose key challenges, involving many critical variables closely related to formulation composition, process parameters, and manufacturing environment. This paper systematically reviews the application of different freeze-drying technologies in mRNA vaccines and the optimization strategy of lyophilized mRNA vaccines, aiming to provide theoretical foundation and guidance for optimizing freeze-drying processes, enhancing vaccine stability and expanding their application scope.
Recent advances in freeze-drying technologies for mRNA vaccines against infectious diseases.
Jinghu Lou,Zhineng Wu,Yi Cheng,Meng Li,Nan Liu,Zengming Wang,Xiang Gao,Aiping Zheng,Hui Zhang
Published 2025 in International journal of pharmaceutics
ABSTRACT
PUBLICATION RECORD
- Publication year
2025
- Venue
International journal of pharmaceutics
- Publication date
2025-11-01
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
Showing 1-1 of 1 citing papers · Page 1 of 1